Samueli Integrative Cancer Pioneering Institute
The Samueli Institute was born in 2023 from a rare convergence of bold visions, united by a belief in the power of integrative translational cancer research to inspire hope and save lives.
With access to Clalit's rich, multidisciplinary and longitudinal datasets, spanning over 5 million Israelis across community and hospital settings, the institute serves as an impact amplifier for applied cancer research, powering early detection, prediction, and the development of novel treatments through an agile, bedside-to-bench-to-bedside model.
The Institute is anchored within the renowned Davidoff Cancer Center at Rabin Medical Center, pioneering patient-centric care that integrates clinical excellence, advanced therapies and healing.
Supported by the visionary Samueli Foundation, the Institute is uniquely positioned at the nexus of medical innovation and real-world data.
Our scientific fields of impact
Harnessing a powerful data nexus and advanced AI, we drive early detection, diagnostic, predictive and prognostic models in untapped clinical fields, shaping the future of precision oncology.
Ronen TalChief Data Officer
We pioneer proprietary research and therapy development to deliver next-generation personalized cell and gene therapies that harness the immune system, leveraging our point-of-care R&D facility.
Prof. Michal Besser, PhDChief Technology Officer
We lead novel clinical research on the impact of converging conventional and complementary approaches and treatments to generate a new standard of integrative cancer care.
Daphna MurvitzChief Integrative Medicine Officer
Open positions